BUZZ-Valeant Pharmaceuticals Inc: Up after lenders agree to loan amendment
** Canadian drugmaker's U.S.-listed shares up 2.5 pct at $30.80 in early trading
** Says its lenders had approved an amendment to its credit facility, giving it more flexibility to sell assets and repay loans by taking on other debt
** Valeant, whose long-term debt stood at about $31 billion as of June 30, has been working to restore investor trust after a year of bad news
** Up to Wednesday's close, stock had fallen 70 pct YTD
© Thomson Reuters 2017 All rights reserved.